Radiation dose rates from adult patients undergoing nuclear medicine investigations
- PMID: 1945188
- DOI: 10.1097/00006231-199109000-00003
Radiation dose rates from adult patients undergoing nuclear medicine investigations
Abstract
Adult patients undergoing nuclear medicine investigations may subsequently come into close contact with members of the public and hospital staff. In order to expand the available dosimetry and derive appropriate recommendations, dose rates were measured at 0.1, 0.5 and 1.0 m from 80 adult patients just before they left the nuclear medicine department after undergoing one of eight 99Tcm studies, an 123I thyroid, an 111In leucocyte or a 201Tl cardiac scan. The maximum departure dose rates at these distances of 150, 30 and 7.3 microSv h-1 were greater than those found in similar published studies of adult and paediatric patients. To limit the dose to an infant to less than 1 mSv, an 111In leucocyte scan is the only investigation for which it may be necessary to restrict close contact between the infant and a radioactive parent, depending on the dose rate near the surface of the patient, the parent's habits and how fretful is the infant. It is unlikely that a ward nurse will receive a dose of 60 microSv in a working day if caring for just one radioactive adult patient, unless the patient is classified as totally helpless and has undergone a 99Tcm marrow, bone or brain scan. The data and revised calculations of effective exposure times based on a total close contact time of 9 h in every 24 h period should allow worst case estimates of radiation dose to be made and recommendations to be formulated for other circumstances, including any future legislative changes in dose limits or derived levels.
Similar articles
-
Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.Eur J Nucl Med. 1995 Oct;22(10):1173-9. doi: 10.1007/BF00800600. Eur J Nucl Med. 1995. PMID: 8542902
-
Radiation dose rates from paediatric patients undergoing 99Tcm investigations.Nucl Med Commun. 1991 Aug;12(8):709-18. Nucl Med Commun. 1991. PMID: 1780110
-
Dose rate measurements from radiopharmaceuticals: implications for nuclear medicine staff and for children with radioactive parents.Nucl Med Commun. 1999 Feb;20(2):179-87. Nucl Med Commun. 1999. PMID: 10088169
-
Exposure of critical groups to nuclear medicine patients.Appl Radiat Isot. 1999 Jan;50(1):89-111. doi: 10.1016/s0969-8043(98)00074-8. Appl Radiat Isot. 1999. PMID: 10028630 Review.
-
Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.J Radiol Prot. 2001 Dec;21(4):381-92. doi: 10.1088/0952-4746/21/4/307. J Radiol Prot. 2001. PMID: 11787894 Review.
Cited by
-
Radiation safety measures in diagnostic nuclear medicine, based on the potential radiation dose emitted by radioactive patients.Radiol Bras. 2023 Jan-Feb;56(1):13-20. doi: 10.1590/0100-3984.2022.0064. Radiol Bras. 2023. PMID: 36926359 Free PMC article.
-
Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.Eur J Nucl Med. 1995 Oct;22(10):1173-9. doi: 10.1007/BF00800600. Eur J Nucl Med. 1995. PMID: 8542902
-
Radiation protection for the parent and child in diagnostic nuclear medicine.Eur J Nucl Med. 1991;18(12):940-3. doi: 10.1007/BF00180411. Eur J Nucl Med. 1991. PMID: 1778202 No abstract available.
-
The excretion of radiopharmaceuticals in human breast milk: additional data and dosimetry.Eur J Nucl Med. 1994 Feb;21(2):144-53. doi: 10.1007/BF00175762. Eur J Nucl Med. 1994. PMID: 8162938 Review.
-
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.Eur J Nucl Med. 1996 Feb;23(2):123-30. doi: 10.1007/BF01731834. Eur J Nucl Med. 1996. PMID: 8925845
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical